These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Efavirenz in an obese HIV-infected patient--a report and an in vitro-in vivo extrapolation model indicate risk of underdosing. de Roche M, Siccardi M, Stoeckle M, Livio F, Back D, Battegay M, Marzolini C. Antivir Ther; 2012 Jun; 17(7):1381-4. PubMed ID: 22910127 [Abstract] [Full Text] [Related]
48. Plasma concentrations of efavirenz are associated with body weight in HIV-positive individuals. Poeta J, Linden R, Antunes MV, Real L, Menezes AM, Ribeiro JP, Sprinz E. J Antimicrob Chemother; 2011 Nov; 66(11):2601-4. PubMed ID: 21890538 [Abstract] [Full Text] [Related]